Influenza: Current Scenario Iminent Pandemics and Contingency Plan
Abstract
Recent events related to the geographic expansion of the highly pathogenic avian influenza virus type A (H5N1), with reports of human occurrences – centered in Southeast Asia – clearly define the possible emergence of a pandemy of influenza, with significant impact on global economics. This paper describes the current scenario of human and avian influenza, characteristics of human infection with type A (H5N1) influenza virus and revises the major recommendations issued by the World Health Organization – WHO – regarding clinical handling of these hazards as well as prevention and control measures. The paper also issues information regarding development of contingency planning to face a possible influenza pandemic, emphasizing the most important propositions.
Downloads
Metrics
References
1. Ligon BL. Avian influenza virus H5N1: A review of its history and information regarding its potential to cause the next pandemic. Semin Pediatr Infect Dis 2005; 16: 326-335.
2. Moscova A. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353: 1363-1373.
3. WHO – The Writing Committee of the World Health Organization Consultation on Human Influenza A/H5. Avian Influenza A (H5N1) infections in humans. N Engl J Med 2005; 353: 1374-1385.
4. WHO – World Health Organization, 2005. Avian influenza – new areas with infection in birds – update 34.Disponível em: http://www.who.int/crs/don/2005_10_13/en/print.html. [Acesso em 14/10/2005].
5. WHO – World Health Organization, 2004. WHO interim guidelines on clinical management of humans infected by influenza A (H5N1).WHO guidelines 20 Feb 2004.
6. WHO – World Health Organization, 2005. Cumulative number of confirmed human cases of Avian Influenza A(H5N1)reported to WHO. Disponível em: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2005_10_24/en/index.html [Acesso em 24/10/2005].
7. WHO – World Health Organization, 2005. WHO global influenza preparedness plan. Disponível em: http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_5/ en/index.html. [Acesso em 14/10/2005].
8. WHO – World Health Organization. Recommended composition of influenza virus vaccines for use in the 2006 southern hemisphere influenza season. Disponível em: http://www.who.int/csr/disease/ influenza/recommendations2006south/en/index.html [Acesso em 14/10/2005].
9. MAPA. Ministério da Agricultura, Pecuária e Abastecimento. Nota Técnica - PNSA nº 01/2004. Influenza Aviária.Disponível em: http://www.agricultura.gov.br/. [Acesso em 23/10/2005].
10. MS. Ministério da Saúde. Influenza – Vigilância Epidemiológica no Brasil – Situação Epidemiológica. Disponível em: http://portal.saude.gov.br/portal/svs/visualizar_texto.cfm?idtxt=21728 [Acesso em 14/10/2005].
11. Gani, R., Hughes, H., Fleming, D. et al. Potential Impact of Antiviral Drug Use during Influenza Pandemic. Emerg Infect Dis 2005; vol 11, Nº 9.
12. Health Canada. Canadian Pandemic Influenza Plan, Health Canada; 2004. [cited 2005 Mar 1]. Disponível em: http://www.phac-aspc.gc.ca/cpip-pclcpi/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2006 Telma Regina M. P.Carvalhanas, Helena Aparecida Barbosa, Sônia Regina T. Silva Ramos, Terezinha Maria de Paiva
This work is licensed under a Creative Commons Attribution 4.0 International License.
